0 XP   0   0   0

Integrated Biopharma Inc
Buy, Hold or Sell?

I guess you are interested in Integrated Biopharma Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Integrated Biopharma Inc

Let's start. I'm going to help you getting a better view of Integrated Biopharma Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Integrated Biopharma Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Integrated Biopharma Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Integrated Biopharma Inc. The closing price on 2022-09-30 was $0.44 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Integrated Biopharma Inc Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Integrated Biopharma Inc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Integrated Biopharma Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Integrated Biopharma Inc to the Packaged Foods industry mean.
  • A Net Profit Margin of 6.9% means that $0.07 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Integrated Biopharma Inc:

  • The MRQ is 11.3%. The company is making a huge profit. +2
  • The TTM is 6.9%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ11.3%TTM6.9%+4.4%
TTM6.9%YOY12.3%-5.4%
TTM6.9%5Y6.2%+0.6%
5Y6.2%10Y4.6%+1.7%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ11.3%3.2%+8.1%
TTM6.9%2.4%+4.5%
YOY12.3%3.6%+8.7%
5Y6.2%2.9%+3.3%
10Y4.6%3.0%+1.6%
1.1.2. Return on Assets

Shows how efficient Integrated Biopharma Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Integrated Biopharma Inc to the Packaged Foods industry mean.
  • 3.7% Return on Assets means that Integrated Biopharma Inc generated $0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Integrated Biopharma Inc:

  • The MRQ is 5.9%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 3.7%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ5.9%TTM3.7%+2.2%
TTM3.7%YOY7.9%-4.2%
TTM3.7%5Y3.9%-0.2%
5Y3.9%10Y3.0%+0.9%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ5.9%0.9%+5.0%
TTM3.7%0.9%+2.8%
YOY7.9%1.1%+6.8%
5Y3.9%1.0%+2.9%
10Y3.0%1.0%+2.0%
1.1.3. Return on Equity

Shows how efficient Integrated Biopharma Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Integrated Biopharma Inc to the Packaged Foods industry mean.
  • 8.0% Return on Equity means the company generated $0.08 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Integrated Biopharma Inc:

  • The MRQ is 8.0%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 5.7%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ8.0%TTM5.7%+2.4%
TTM5.7%YOY18.3%-12.7%
TTM5.7%5Y20.7%-15.0%
5Y20.7%10Y17.7%+3.0%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ8.0%2.1%+5.9%
TTM5.7%1.9%+3.8%
YOY18.3%2.4%+15.9%
5Y20.7%2.1%+18.6%
10Y17.7%2.1%+15.6%

1.2. Operating Efficiency of Integrated Biopharma Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Integrated Biopharma Inc is operating .

  • Measures how much profit Integrated Biopharma Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Integrated Biopharma Inc to the Packaged Foods industry mean.
  • An Operating Margin of 3.3% means the company generated $0.03  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Integrated Biopharma Inc:

  • The MRQ is 3.3%. The company is operating less efficient.
  • The TTM is 4.8%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ3.3%TTM4.8%-1.5%
TTM4.8%YOY11.6%-6.8%
TTM4.8%5Y6.4%-1.6%
5Y6.4%10Y4.9%+1.5%
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3%5.1%-1.8%
TTM4.8%3.1%+1.7%
YOY11.6%4.7%+6.9%
5Y6.4%4.5%+1.9%
10Y4.9%3.6%+1.3%
1.2.2. Operating Ratio

Measures how efficient Integrated Biopharma Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Packaged Foods industry mean).
  • An Operation Ratio of 1.86 means that the operating costs are $1.86 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Integrated Biopharma Inc:

  • The MRQ is 1.862. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.836. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.862TTM1.836+0.026
TTM1.836YOY-0.091+1.927
TTM1.8365Y0.625+1.211
5Y0.62510Y0.772-0.147
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8621.678+0.184
TTM1.8361.576+0.260
YOY-0.0911.489-1.580
5Y0.6251.374-0.749
10Y0.7721.155-0.383

1.3. Liquidity of Integrated Biopharma Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Integrated Biopharma Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Packaged Foods industry mean).
  • A Current Ratio of 3.16 means the company has $3.16 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Integrated Biopharma Inc:

  • The MRQ is 3.159. The company is very able to pay all its short-term debts. +2
  • The TTM is 2.399. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ3.159TTM2.399+0.760
TTM2.399YOY1.496+0.903
TTM2.3995Y1.439+0.960
5Y1.43910Y1.060+0.379
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1591.617+1.542
TTM2.3991.587+0.812
YOY1.4961.579-0.083
5Y1.4391.551-0.112
10Y1.0601.417-0.357
1.3.2. Quick Ratio

Measures if Integrated Biopharma Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Packaged Foods industry mean)
  • A Quick Ratio of 0.93 means the company can pay off $0.93 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Integrated Biopharma Inc:

  • The MRQ is 0.929. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.668. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.929TTM0.668+0.260
TTM0.668YOY0.559+0.109
TTM0.6685Y0.465+0.203
5Y0.46510Y0.378+0.088
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9290.516+0.413
TTM0.6680.565+0.103
YOY0.5590.619-0.060
5Y0.4650.608-0.143
10Y0.3780.589-0.211

1.4. Solvency of Integrated Biopharma Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Integrated Biopharma Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Packaged Foods industry mean).
  • A Debt to Asset Ratio of 0.26 means that Integrated Biopharma Inc assets are financed with 26.4% credit (debt) and the remaining percentage (100% - 26.4%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Integrated Biopharma Inc:

  • The MRQ is 0.264. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.361. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.264TTM0.361-0.097
TTM0.361YOY0.610-0.249
TTM0.3615Y0.830-0.469
5Y0.83010Y1.276-0.446
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2640.492-0.228
TTM0.3610.485-0.124
YOY0.6100.491+0.119
5Y0.8300.488+0.342
10Y1.2760.487+0.789
1.4.2. Debt to Equity Ratio

Measures if Integrated Biopharma Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Packaged Foods industry mean).
  • A Debt to Equity ratio of 35.9% means that company has $0.36 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Integrated Biopharma Inc:

  • The MRQ is 0.359. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.577. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.359TTM0.577-0.218
TTM0.577YOY1.728-1.151
TTM0.5775Y10.057-9.479
5Y10.05710Y9.581+0.476
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3590.965-0.606
TTM0.5770.946-0.369
YOY1.7280.933+0.795
5Y10.0570.983+9.074
10Y9.5810.967+8.614

2. Market Valuation of Integrated Biopharma Inc

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Integrated Biopharma Inc.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of 3.89 means the investor is paying $3.89 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Integrated Biopharma Inc:

  • The EOD is 3.425. Very good. +2
  • The MRQ is 3.892. Very good. +2
  • The TTM is 3.938. Very good. +2
Trends
Current periodCompared to+/- 
EOD3.425MRQ3.892-0.467
MRQ3.892TTM3.938-0.046
TTM3.938YOY4.239-0.301
TTM3.9385Y3.562+0.377
5Y3.56210Y2.140+1.421
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD3.42512.072-8.647
MRQ3.89213.044-9.152
TTM3.93814.551-10.613
YOY4.23913.577-9.338
5Y3.56216.782-13.220
10Y2.14016.291-14.151
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Integrated Biopharma Inc.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Integrated Biopharma Inc:

  • The MRQ is -0.074. Very Bad. -2
  • The TTM is 0.059. Very good. +2
Trends
Current periodCompared to+/- 
MRQ-0.074TTM0.059-0.133
TTM0.059YOY0.039+0.020
TTM0.0595Y0.070-0.011
5Y0.07010Y-0.015+0.085
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.0740.003-0.077
TTM0.059-0.005+0.064
YOY0.0390.031+0.008
5Y0.070-0.019+0.089
10Y-0.015-0.010-0.005

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Integrated Biopharma Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Packaged Foods industry mean).
  • A PB ratio of 0.81 means the investor is paying $0.81 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Integrated Biopharma Inc:

  • The EOD is 0.709. Very good. +2
  • The MRQ is 0.806. Very good. +2
  • The TTM is 1.557. Good. +1
Trends
Current periodCompared to+/- 
EOD0.709MRQ0.806-0.097
MRQ0.806TTM1.557-0.751
TTM1.557YOY2.504-0.947
TTM1.5575Y3.120-1.563
5Y3.12010Y1.368+1.751
Compared to industry (Packaged Foods)
PeriodCompanyIndustry (mean)+/- 
EOD0.7091.534-0.825
MRQ0.8061.715-0.909
TTM1.5571.847-0.290
YOY2.5041.956+0.548
5Y3.1201.696+1.424
10Y1.3681.348+0.020

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Integrated Biopharma Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--0.6200.557+11%0.333+86%0.155+301%-0.142+123%
Book Value Per Share Growth--0.0510.035+47%0.069-26%0.045+14%0.028+83%
Current Ratio--3.1592.399+32%1.496+111%1.439+120%1.060+198%
Debt To Asset Ratio--0.2640.361-27%0.610-57%0.830-68%1.276-79%
Debt To Equity Ratio--0.3590.577-38%1.728-79%10.057-96%9.581-96%
Dividend Per Share----0%-0%-0%-0%
Eps--0.0500.032+55%0.067-26%0.031+59%0.025+103%
Eps Growth---52.29717.506-399%116.370-145%37.496-239%-59.280+13%
Gains Per Share--0.0510.035+47%0.069-26%0.045+14%0.028+83%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.925+8%
Net Profit Margin--0.1130.069+64%0.123-8%0.062+80%0.046+146%
Operating Margin--0.0330.048-31%0.116-72%0.064-49%0.049-33%
Operating Ratio--1.8621.836+1%-0.091+105%0.625+198%0.772+141%
Pb Ratio0.709-14%0.8061.557-48%2.504-68%3.120-74%1.368-41%
Pe Ratio3.425-14%3.8923.938-1%4.239-8%3.562+9%2.140+82%
Peg Ratio---0.0740.059-227%0.039-290%0.070-207%-0.015-80%
Price Per Share0.440-14%0.5000.845-41%0.837-40%0.470+6%0.318+57%
Quick Ratio--0.9290.668+39%0.559+66%0.465+100%0.378+146%
Return On Assets--0.0590.037+61%0.079-25%0.039+52%0.030+97%
Return On Equity--0.0800.057+42%0.183-56%0.207-61%0.177-55%
 EOD+3 -0MRQTTM+15 -3YOY+9 -95Y+12 -610Y+14 -5

3.2. Fundamental Score

Let's check the fundamental score of Integrated Biopharma Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-153.425
Price to Book Ratio (EOD)Between0-10.709
Net Profit Margin (MRQ)Greater than00.113
Operating Margin (MRQ)Greater than00.033
Quick Ratio (MRQ)Greater than10.929
Current Ratio (MRQ)Greater than13.159
Debt to Asset Ratio (MRQ)Less than10.264
Debt to Equity Ratio (MRQ)Less than10.359
Return on Equity (MRQ)Greater than0.150.080
Return on Assets (MRQ)Greater than0.050.059
Total8/10 (80.0%)

3.3. Technical Score

Let's check the technical score of Integrated Biopharma Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.767
Ma 20Greater thanMa 500.516
Ma 50Greater thanMa 1000.511
Ma 100Greater thanMa 2000.565
OpenGreater thanClose0.440
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets25,250
Total Liabilities6,675
Total Stockholder Equity18,575
 As reported
Total Liabilities 6,675
Total Stockholder Equity+ 18,575
Total Assets = 25,250

Assets

Total Assets25,250
Total Current Assets16,626
Long-term Assets16,626
Total Current Assets
Cash And Cash Equivalents 331
Net Receivables 4,888
Inventory 11,055
Other Current Assets 340
Total Current Assets  (as reported)16,626
Total Current Assets  (calculated)16,614
+/- 12
Long-term Assets
Property Plant Equipment 3,777
Other Assets 4,847
Long-term Assets  (as reported)8,624
Long-term Assets  (calculated)8,624
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities5,263
Long-term Liabilities1,412
Total Stockholder Equity18,575
Total Current Liabilities
Short Long Term Debt 133
Accounts payable 3,209
Total Current Liabilities  (as reported)5,263
Total Current Liabilities  (calculated)3,342
+/- 1,921
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,869
Long-term Liabilities  (as reported)1,412
Long-term Liabilities  (calculated)1,869
+/- 457
Total Stockholder Equity
Common Stock60
Total Stockholder Equity (as reported)18,575
Total Stockholder Equity (calculated)60
+/- 18,515
Other
Capital Stock60
Common Stock Shares Outstanding 29,950
Net Invested Capital 18,761
Net Tangible Assets 18,575
Net Working Capital 11,363



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-31
> Total Assets 
10,400
8,580
9,748
10,135
9,984
9,838
10,604
9,964
9,338
10,007
9,925
11,192
12,447
20,827
22,358
24,480
24,503
31,813
30,170
28,234
31,227
26,242
27,964
29,527
30,810
37,605
40,155
41,843
43,610
44,209
46,564
42,087
34,892
31,357
30,165
22,647
19,781
16,483
16,195
16,627
14,503
13,848
13,401
13,660
13,228
13,650
13,409
11,530
10,752
11,877
12,174
13,587
12,727
12,611
12,567
11,766
10,322
11,583
13,144
13,661
12,420
11,623
12,077
14,220
14,112
14,085
14,647
14,998
13,614
15,196
13,381
15,648
14,621
14,568
19,724
22,575
22,221
19,790
19,641
19,971
20,645
22,944
24,630
25,263
26,131
25,440
24,336
27,071
27,697
25,250
25,25027,69727,07124,33625,44026,13125,26324,63022,94420,64519,97119,64119,79022,22122,57519,72414,56814,62115,64813,38115,19613,61414,99814,64714,08514,11214,22012,07711,62312,42013,66113,14411,58310,32211,76612,56712,61112,72713,58712,17411,87710,75211,53013,40913,65013,22813,66013,40113,84814,50316,62716,19516,48319,78122,64730,16531,35734,89242,08746,56444,20943,61041,84340,15537,60530,81029,52727,96426,24231,22728,23430,17031,81324,50324,48022,35820,82712,44711,1929,92510,0079,3389,96410,6049,8389,98410,1359,7488,58010,400
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,698
0
0
0
0
0
0
0
0
9,239
7,846
9,166
10,486
11,117
9,994
9,322
9,833
11,939
11,730
12,070
12,704
13,087
11,636
12,551
10,635
13,212
12,294
12,154
13,733
16,540
16,350
14,079
14,083
14,536
15,297
16,461
18,574
19,099
20,526
17,998
16,984
19,347
20,043
16,626
16,62620,04319,34716,98417,99820,52619,09918,57416,46115,29714,53614,08314,07916,35016,54013,73312,15412,29413,21210,63512,55111,63613,08712,70412,07011,73011,9399,8339,3229,99411,11710,4869,1667,8469,2390000000011,6980000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,201
5,628
1,308
2,156
1,524
3,880
1,583
873
1,082
381
781
570
1,987
1,518
735
648
1,048
1,583
606
563
1,386
388
649
145
216
124
285
55
480
819
868
983
826
580
886
572
585
561
951
896
593
567
697
597
284
54
62
228
365
45
431
475
525
67
565
402
369
43
105
210
57
162
264
331
331264162572101054336940256567525475431453652286254284597697567593896951561585572886580826983868819480552851242161456493881,3865636061,5831,0486487351,5181,9875707813811,0828731,5833,8801,5242,1561,3085,6282,20100000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,000
2,000
2,000
0
0
2,000
0
0
0
0
0
0
0
0
0
0
0
0
0
823
823
823
823
823
823
823
684
684
684
684
684
532
532
532
532
501
501
501
501
501
501
501
501
465
382
215
263
196
0
0
0
84
0
0
0
0
0
0
0
0
0
0
0
0
0000000000008400019626321538246550150150150150150150150153253253253268468468468468482382382382382382382300000000000002,000002,0002,0002,00000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,960
0
0
0
0
0
0
0
0
2,289
1,940
2,179
2,297
3,385
2,788
2,638
2,803
3,991
3,634
3,135
3,765
4,420
2,706
4,843
2,673
5,171
3,198
4,467
3,381
4,517
4,957
4,973
3,904
4,879
4,272
5,507
4,855
4,537
7,917
9,044
3,801
5,467
6,170
4,888
4,8886,1705,4673,8019,0447,9174,5374,8555,5074,2724,8793,9044,9734,9574,5173,3814,4673,1985,1712,6734,8432,7064,4203,7653,1353,6343,9912,8032,6382,7883,3852,2972,1791,9402,289000000001,9600000000000000000000000000000000000000000000000
       Other Current Assets 
358
390
456
486
542
392
983
403
384
170
257
333
886
806
2,319
4,215
2,436
1,281
1,752
1,439
1,576
822
638
627
1,346
4,508
4,823
4,670
4,751
4,175
4,153
5,499
3,560
1,958
2,350
953
1,080
754
699
783
649
556
560
482
3,337
3,895
3,843
3,538
454
391
439
332
344
339
342
331
370
306
389
1,463
1,210
334
522
368
1,211
518
673
686
353
510
636
505
479
481
387
443
413
461
407
3,353
394
317
594
603
3,050
2,749
504
597
513
340
3405135975042,7493,0506035943173943,3534074614134433874814795056365103536866735181,2113685223341,2101,4633893063703313423393443324393914543,5383,8433,8953,3374825605566497836997541,0809532,3501,9583,5605,4994,1534,1754,7514,6704,8234,5081,3466276388221,5761,4391,7521,2812,4364,2152,319806886333257170384403983392542486456390358
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,711
0
0
0
0
0
0
0
0
2,527
2,476
2,417
2,658
1,483
1,649
2,301
2,080
2,281
1,486
1,780
1,536
1,498
1,978
1,601
2,746
1,860
2,327
1,651
2,365
2,522
2,472
5,062
4,914
2,383
596
6,483
1,606
1,857
1,637
1,742
7,352
7,724
7,654
8,624
8,6247,6547,7247,3521,7421,6371,8571,6066,4835962,3834,9145,0622,4722,5222,3651,6512,3271,8602,7461,6011,9781,4981,5361,7801,4862,2812,0802,3011,6491,4832,6582,4172,4762,527000000001,7110000000000000000000000000000000000000000000000
       Property Plant Equipment 
1,409
1,367
2,574
2,502
2,438
2,350
2,364
2,328
2,346
2,308
2,436
2,360
2,325
2,294
5,156
5,943
6,785
6,857
7,677
7,546
7,451
4,664
4,510
4,350
4,222
4,173
4,066
4,084
4,168
4,377
4,275
4,132
3,942
3,886
3,688
3,442
1,940
1,865
1,824
1,859
1,790
1,719
1,780
1,768
1,631
1,598
1,519
1,445
1,466
1,449
1,359
1,289
1,299
1,235
1,168
1,205
1,231
1,239
1,531
1,483
1,431
1,373
1,368
1,488
1,486
1,567
1,536
1,498
1,654
1,601
1,632
1,684
1,670
1,651
1,604
1,806
1,802
1,778
1,745
1,720
1,698
4,520
1,670
1,651
1,637
1,742
3,982
3,913
3,931
3,777
3,7773,9313,9133,9821,7421,6371,6511,6704,5201,6981,7201,7451,7781,8021,8061,6041,6511,6701,6841,6321,6011,6541,4981,5361,5671,4861,4881,3681,3731,4311,4831,5311,2391,2311,2051,1681,2351,2991,2891,3591,4491,4661,4451,5191,5981,6311,7681,7801,7191,7901,8591,8241,8651,9403,4423,6883,8863,9424,1324,2754,3774,1684,0844,0664,1734,2224,3504,5104,6647,4517,5467,6776,8576,7855,9435,1562,2942,3252,3602,4362,3082,3462,3282,3642,3502,4382,5022,5741,3671,409
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,643
688
688
688
688
145
145
145
145
145
145
145
145
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000000000000000000001451451451451451451451456886886886881,6430000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
507
497
487
1,020
3,678
4,167
4,247
4,178
4,639
4,532
3,618
3,547
3,721
3,820
4,161
4,111
4,056
5,531
6,263
6,114
6,106
6,051
5,165
1,743
1,683
1,631
1,570
1,535
1,501
1,466
1,432
1,397
1,363
0
0
0
0
1,188
1,154
1,119
1,085
1,051
1,017
983
948
914
880
846
811
777
743
712
688
663
235
0
0
0
134
0
0
0
33
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000330001340002356636887127437778118468809149489831,0171,0511,0851,1191,1541,18800001,3631,3971,4321,4661,5011,5351,5701,6311,6831,7435,1656,0516,1066,1146,2635,5314,0564,1114,1613,8203,7213,5473,6184,5324,6394,1784,2474,1673,6781,02048749750700000000000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
192
0
0
0
0
0
0
0
0
374
331
298
281
0
218
185
0
105
0
213
0
0
324
0
237
176
124
0
121
57
48
3,284
3,169
86
3,054
2,824
2,780
2,656
0
0
0
0
0
0
0000002,6562,7802,8243,054863,1693,28448571210124176237032400213010501852180281298331374000000001920000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
877
0
533
0
640
659
622
0
0
577
0
0
0
0
0
0
0
0
0
0
000000000057700622659640053308770000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
3,521
2,207
2,452
3,459
3,613
3,646
3,591
2,743
1,976
2,422
2,154
3,094
2,773
2,572
7,745
7,939
9,062
7,416
7,463
7,816
9,395
10,272
10,028
10,322
11,234
11,872
13,900
20,493
20,866
24,212
27,733
25,919
18,579
20,494
18,373
18,487
19,139
18,929
17,928
19,074
18,702
19,544
18,928
19,538
19,959
21,345
20,731
19,629
19,585
22,260
23,529
24,125
23,797
22,901
22,559
21,360
20,366
21,738
22,896
22,864
21,729
20,939
21,142
23,341
23,193
22,412
22,321
22,728
21,091
21,125
19,485
22,095
20,677
19,804
19,529
22,109
20,832
17,897
17,421
16,777
16,501
16,877
17,514
16,830
16,382
11,106
9,445
11,001
10,722
6,675
6,67510,72211,0019,44511,10616,38216,83017,51416,87716,50116,77717,42117,89720,83222,10919,52919,80420,67722,09519,48521,12521,09122,72822,32122,41223,19323,34121,14220,93921,72922,86422,89621,73820,36621,36022,55922,90123,79724,12523,52922,26019,58519,62920,73121,34519,95919,53818,92819,54418,70219,07417,92818,92919,13918,48718,37320,49418,57925,91927,73324,21220,86620,49313,90011,87211,23410,32210,02810,2729,3957,8167,4637,4169,0627,9397,7452,5722,7733,0942,1542,4221,9762,7433,5913,6463,6133,4592,4522,2073,521
   > Total Current Liabilities 
3,480
1,629
2,407
3,418
3,585
3,553
3,569
2,725
1,962
2,412
2,149
3,089
2,768
2,572
7,573
7,939
9,062
7,416
7,463
7,816
9,395
10,272
10,028
10,322
11,234
11,872
13,900
20,493
20,866
15,862
19,483
25,919
14,864
10,038
7,729
14,579
15,166
14,890
15,088
15,983
18,702
19,544
18,928
19,538
19,959
21,345
20,731
19,629
19,585
12,203
12,496
13,192
12,766
12,416
12,117
11,071
10,207
11,653
12,933
13,441
12,542
11,865
12,149
14,362
12,304
11,824
11,791
11,988
10,536
11,155
9,865
12,531
11,313
16,180
12,576
15,511
14,437
12,353
12,542
12,293
12,388
13,099
14,644
14,265
14,372
9,236
7,701
9,384
9,233
5,263
5,2639,2339,3847,7019,23614,37214,26514,64413,09912,38812,29312,54212,35314,43715,51112,57616,18011,31312,5319,86511,15510,53611,98811,79111,82412,30414,36212,14911,86512,54213,44112,93311,65310,20711,07112,11712,41612,76613,19212,49612,20319,58519,62920,73121,34519,95919,53818,92819,54418,70215,98315,08814,89015,16614,5797,72910,03814,86425,91919,48315,86220,86620,49313,90011,87211,23410,32210,02810,2729,3957,8167,4637,4169,0627,9397,5732,5722,7683,0892,1492,4121,9622,7253,5693,5533,5853,4182,4071,6293,480
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,305
0
0
0
0
0
0
0
0
4,832
4,017
4,709
5,335
6,205
5,240
5,193
4,926
6,689
5,040
5,220
5,844
5,758
5,454
5,794
5,556
6,095
5,553
5,667
5,550
7,229
7,161
5,834
4,799
6,337
4,574
6,869
5,659
6,331
5,687
3,630
0
0
0
0
00003,6305,6876,3315,6596,8694,5746,3374,7995,8347,1617,2295,5505,6675,5536,0955,5565,7945,4545,7585,8445,2205,0406,6894,9265,1935,2406,2055,3354,7094,0174,8320000000012,3050000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,950
4,739
15,261
1,031
869
852
6,042
851
903
7,161
6,881
5,852
6,337
4,574
6,869
5,659
6,331
5,687
3,630
1,509
3,158
2,728
133
1332,7283,1581,5093,6305,6876,3315,6596,8694,5746,3375,8526,8817,1619038516,0428528691,03115,2614,7394,9500000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
2,527
1,358
1,062
2,054
2,261
2,176
2,118
1,993
1,550
1,632
1,366
2,408
2,182
1,978
2,293
2,482
3,617
1,937
1,875
2,257
3,507
3,987
3,902
3,710
5,205
4,124
5,913
3,896
3,558
3,594
5,551
5,766
4,300
6,630
4,503
5,143
6,355
5,788
5,153
5,915
5,672
6,440
5,264
5,659
4,175
5,152
5,608
3,366
4,839
6,481
6,407
7,028
6,520
5,883
5,625
6,239
6,190
6,944
7,598
7,236
7,302
11,804
7,223
12,858
12,460
11,886
5,947
12,263
5,797
5,361
10,163
12,117
11,399
10,513
7,026
8,282
7,276
3,855
5,106
5,478
7,330
4,358
8,491
7,441
8,190
5,106
4,221
4,243
4,690
3,209
3,2094,6904,2434,2215,1068,1907,4418,4914,3587,3305,4785,1063,8557,2768,2827,02610,51311,39912,11710,1635,3615,79712,2635,94711,88612,46012,8587,22311,8047,3027,2367,5986,9446,1906,2395,6255,8836,5207,0286,4076,4814,8393,3665,6085,1524,1755,6595,2646,4405,6725,9155,1535,7886,3555,1434,5036,6304,3005,7665,5513,5943,5583,8965,9134,1245,2053,7103,9023,9873,5072,2571,8751,9373,6172,4822,2931,9782,1822,4081,3661,6321,5501,9932,1182,1762,2612,0541,0621,3582,527
       Other Current Liabilities 
376
221
300
447
506
644
413
406
156
656
647
638
577
540
649
633
684
732
834
857
1,187
1,613
1,454
1,940
1,357
2,505
2,336
2,222
2,897
3,574
3,676
3,048
3,422
3,328
3,226
2,420
1,579
1,644
2,246
1,963
1,571
1,357
1,562
1,476
3,179
3,588
2,818
3,658
2,141
1,549
1,594
1,438
1,296
1,122
1,279
1,190
1,284
1,309
1,199
1,291
1,474
3,942
1,189
3,794
5,554
1,211
1,118
4,707
1,120
1,184
3,766
3,883
1,264
3,624
0
0
0
5,544
0
3,058
484
488
494
3,058
495
2,370
0
0
0
0
00002,3704953,0584944884843,05805,5440003,6241,2643,8833,7661,1841,1204,7071,1181,2115,5543,7941,1893,9421,4741,2911,1991,3091,2841,1901,2791,1221,2961,4381,5941,5492,1413,6582,8183,5883,1791,4761,5621,3571,5711,9632,2461,6441,5792,4203,2263,3283,4223,0483,6763,5742,8972,2222,3362,5051,3571,9401,4541,6131,187857834732684633649540577638647656156406413644506447300221376
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,289
10,159
10,085
9,963
9,423
9,187
0
8,993
0
139
5,306
10,530
0
9,840
9,970
0
0
3,725
0
3,319
3,077
2,988
5,544
4,879
1,904
4,113
3,778
2,870
2,565
2,010
1,870
1,744
1,617
1,489
1,412
1,4121,4891,6171,7441,8702,0102,5652,8703,7784,1131,9044,8795,5442,9883,0773,31903,725009,9709,840010,5305,30613908,99309,1879,4239,96310,08510,15910,2890000000000000000000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,647
4,500
4,359
4,423
4,302
4,080
0
3,830
0
0
5,306
4,870
0
4,605
4,246
0
0
3,725
0
3,319
3,077
2,988
0
2,177
1,904
1,648
1,436
654
0
40
0
0
0
0
0
000004006541,4361,6481,9042,17702,9883,0773,31903,725004,2464,60504,8705,306003,83004,0804,3024,4234,3594,5004,6470000000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
877
0
533
0
640
659
622
0
0
577
0
0
0
0
0
0
0
0
0
0
000000000057700622659640053308770000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
69
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
350
250
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
563
1,648
991
1,165
696
770
687
677
717
503
56
15
12
15
9
139
76
444
808
715
503
621
436
382
0
0
0
0
2,822
0
0
0
0
0
0
0
0
0
0
0
0
0000000000002,8220000382436621503715808444761399151215565037176776877706961,1659911,648563000000000000000000250350000000000000000000000006900000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
687
677
717
503
56
15
0
15
0
139
0
444
0
0
503
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000503004440139015015565037176776870000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
6,879
6,373
7,296
6,676
6,371
6,192
7,013
7,221
7,362
7,585
7,771
8,098
9,674
18,255
14,613
16,541
15,441
24,397
22,707
20,047
21,461
15,621
17,619
18,972
19,365
25,577
26,137
21,350
22,744
19,997
18,831
16,168
16,313
10,863
11,792
4,160
642
0
0
0
0
0
0
0
0
0
-7,322
0
0
0
0
0
0
0
0
-9,594
-10,044
-10,155
-9,752
-9,203
-9,309
-9,316
-9,065
-9,121
-9,081
-8,327
-7,674
-7,730
-7,477
-5,929
-6,104
-6,447
-6,056
-5,236
195
466
1,389
1,893
2,220
3,194
4,144
6,067
7,116
8,433
9,749
14,334
14,891
16,070
16,975
18,575
18,57516,97516,07014,89114,3349,7498,4337,1166,0674,1443,1942,2201,8931,389466195-5,236-6,056-6,447-6,104-5,929-7,477-7,730-7,674-8,327-9,081-9,121-9,065-9,316-9,309-9,203-9,752-10,155-10,044-9,59400000000-7,3220000000006424,16011,79210,86316,31316,16818,83119,99722,74421,35026,13725,57719,36518,97217,61915,62121,46120,04722,70724,39715,44116,54114,61318,2559,6748,0987,7717,5857,3627,2217,0136,1926,3716,6767,2966,3736,879
   Common Stock
10
10
12
13
13
12
12
12
12
12
12
12
20
20
21
21
21
25
25
25
25
25
25
25
26
26
27
27
28
28
28
29
29
30
40
40
40
40
40
41
41
41
41
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
42
59
59
59
59
59
59
59
59
59
59
60
60
60
60
60
60
606060606060595959595959595959594242424242424242424242424242424242424242424242424242424242424241414141404040404030292928282827272626252525252525252121212020121212121212121313121010
   Retained Earnings 
2,021
1,544
1,218
597
283
95
916
1,124
1,265
1,488
1,674
2,001
2,219
2,382
1,530
1,068
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-51,818
0
0
0
0
0
0
0
0
-54,105
-54,555
-54,670
-54,267
-53,718
-53,824
-53,935
-53,692
-53,756
-53,723
-52,977
-52,328
-52,405
-52,167
-50,631
-50,810
-51,158
-50,770
-49,952
-49,793
-49,547
-48,624
-48,264
-47,952
-46,993
-46,057
-44,156
-43,115
-41,891
-40,650
-36,143
-35,627
-34,596
-33,799
-32,305
-32,305-33,799-34,596-35,627-36,143-40,650-41,891-43,115-44,156-46,057-46,993-47,952-48,264-48,624-49,547-49,793-49,952-50,770-51,158-50,810-50,631-52,167-52,405-52,328-52,977-53,723-53,756-53,692-53,935-53,824-53,718-54,267-54,670-54,555-54,10500000000-51,8180000000000000000000000000000001,0681,5302,3822,2192,0011,6741,4881,2651,124916952835971,2181,5442,021
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44,553
0
0
0
0
0
0
0
0
44,568
44,568
44,572
44,572
44,572
44,572
44,676
44,684
44,692
44,699
44,707
44,711
44,732
44,747
44,759
44,763
44,768
44,771
44,773
50,028
50,053
50,053
50,197
50,212
50,227
50,241
50,263
50,271
50,364
50,438
50,516
0
0
0
0
000050,51650,43850,36450,27150,26350,24150,22750,21250,19750,05350,05350,02844,77344,77144,76844,76344,75944,74744,73244,71144,70744,69944,69244,68444,67644,57244,57244,57244,57244,56844,5680000000044,5530000000000000000000000000000000000000000000000
   Treasury Stock0000-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-99-29-29-29-29-29-29-29-28-29-29-29-29-29-29-29-29-290
   Other Stockholders Equity 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.